The Epidemiology and Treatment of Ankylosing Spondylitis in Korea
- Author:
Seong-Ryul KWON
1
;
Tae-Hwan KIM
;
Tae-Jong KIM
;
Won PARK
;
Seung Cheol SHIM
Author Information
- Publication Type:Review Article
- From:Journal of Rheumatic Diseases 2022;29(4):193-199
- CountryRepublic of Korea
- Language:English
- Abstract: Ankylosing spondylitis is a chronic inflammatory disorder characterized by inflammation of the axial skeleton and sacroiliac joints and to a lesser extent by peripheral arthritis and the involvement of some extra-articular organs. It is paramount for the provision of effective health care delivery to be familiar with the epidemiologic studies on prevalence, mortality, and disability. Furthermore, there is no systematic arrangement of studies related to the treatment of ankylosing spondylitis in Korea. In this review, we addressed Korean ankylosing spondylitis epidemiological studies related to prevalence, genetic factor especially human leucocyte antigen-B27, extra-articular manifestations, infections, mortality, radiologic progression, child-birth, and quality of life. Furthermore, we reviewed Korean ankylosing spondylitis treatment researches about treatment trend, patients’ registration program called The KOrean College of Rheumatology BIOlogics and targeted therapy (KOBIO) registry project, biologics and biosimiliars, complications especially infections, and issues about bony progression. There would be value to further studying the epidemiology and treatment of Korean ankylosing spondylitis.
